Urology · East Lansing, MI
NPI
1609213636
Since 2013
Specialty
Urology
Code 208800000X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
2900 Hannah Blvd Ste 104
East Lansing, MI, 48823
Phone (517) 364-8118
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
1,243 services
Medicare patients, 2024
291
Average age 73
Drug cost, 2024
$365K
1,838 prescriptions
Company payments, 2025
$555
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arya Khatiwoda was code 81003 (clinical chemistry), 280 times for 190 patients. In total Arya Khatiwoda billed 1,243 services in 57 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 280 | 190 | $2.14 | $599 |
| 51798 Ultrasound - Nonspecific | Office | 226 | 174 | $7.77 | $1,756 |
| 99214 Office E&M - Established | Office | 174 | 124 | $95.38 | $17K |
| 99213 Office E&M - Established | Office | 81 | 75 | $59.89 | $4,851 |
| 99204 Office E&M - New | Office | 58 | 58 | $112.84 | $6,545 |
| 51703 Other Organ Systems | Office | 39 | 11 | $113.31 | $4,419 |
| 99222 Hospital E&M - Initial | Facility | 36 | 33 | $107.16 | $3,858 |
| 52000 Cystourethroscopy | Office | 35 | 30 | $174.88 | $6,121 |
| 74420 Standard X-ray | Facility | 33 | 25 | $19.17 | $633 |
| 52332 Cystourethroscopy | Facility | 19 | 16 | $115.13 | $2,187 |
| 51700 Other Organ Systems | Office | 18 | 18 | $53.79 | $968 |
| 52356 Calculus Removal - Urinary | Facility | 18 | 15 | $330.17 | $5,943 |
| 99203 Office E&M - New | Office | 16 | 16 | $73.39 | $1,174 |
| 99211 Office E&M - Established | Office | 15 | 13 | $15.84 | $238 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 15 | $13.47 | $202 |
By year: 2022 $66K for 1,154 services; 2023 $63K for 1,137 services; 2024 $77K for 1,243 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 280 | 190 | $2.14 | $599 |
Medicare prescription drug claims, 2024
In 2024, the drug Arya Khatiwoda prescribed most often to Medicare patients was Tamsulosin Hcl, with 339 prescriptions and refills. In total Arya Khatiwoda wrote 1,838 Medicare prescriptions that cost $365K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 339 | 752 | 108 | $5,590 |
| Finasteride Generic | 216 | 534 | 58 | $3,979 |
| Myrbetriq Mirabegron | 213 | 346 | 73 | $149K |
| Gemtesa Vibegron | 143 | 267 | 44 | $123K |
| Estradiol Generic | 138 | 403 | 73 | $8,195 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 117 | 131 | 66 | $1,475 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 78 | 91 | 59 | $196 |
| Cephalexin Generic | 75 | 101 | 20 | $367 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 64 | 64 | 42 | $499 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 57 | 101 | 17 | $1,303 |
| Mirabegron Er Mirabegron | 55 | 85 | 19 | $28K |
| Solifenacin Succinate Generic | 48 | 102 | 17 | $1,994 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 29 | 61 | Under 11 | $529 |
| Ciprofloxacin Hcl Generic | 27 | 27 | 24 | $114 |
| Potassium Citrate Er Potassium Citrate | 23 | 49 | 11 | $1,722 |
Brand drugs: - claims; generic drugs: 1,395 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arya Khatiwoda $555 ($555 in general payments such as food, travel and fees) from 7 companies. The largest payer was Calyxo, Inc. with $170.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.